Study of multidrug resistance in prevalent Gram-negative bacteria in burn patients in Iran: A systematic review and meta-analysis.
Acinetobacter baumannii
/ drug effects
Anti-Bacterial Agents
/ pharmacology
Burns
/ microbiology
Colistin
/ pharmacology
Databases, Factual
Drug Resistance, Multiple, Bacterial
/ drug effects
Escherichia coli
/ drug effects
Gram-Negative Bacteria
/ drug effects
Gram-Negative Bacterial Infections
/ epidemiology
Hospitalization
Humans
Infection Control
Iran
/ epidemiology
Microbial Sensitivity Tests
Prevalence
Pseudomonas aeruginosa
/ drug effects
Burn patients
Drug resistance
Gram-negative bacteria
Meta-analysis
Journal
Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
19
01
2019
revised:
14
04
2019
accepted:
29
04
2019
pubmed:
8
5
2019
medline:
21
7
2020
entrez:
8
5
2019
Statut:
ppublish
Résumé
Recently, multidrug-resistant (MDR) Gram-negative bacteria (GNB) have become a serious concern causing infections in hospitalised burn patients. This meta-analysis was conducted to detect the prevalence of infections caused by MDR-GNB in hospitalised burn patients in Iran. An electronic search was performed using PubMed, Scopus, Web of Science, EMBASE and Iranian databases. Statistical analysis was performed using STATA13. According to the results of the heterogeneity test, a fixed- or random-effects model was used. Publication bias was detected based on Egger's test. Of 1292 articles identified in the initial search, 107 studies were included in this review. According to the results, the lowest resistance rate was observed in Acinetobacter baumannii and Pseudomonas aeruginosa to colistin, estimated at 21% [95% confidence interval (CI) 2-49%; I The prevalence of MDR-GNB in Iranian burn patients is very high. Thus, a comprehensive infectious control programme, a reduction in the use of antibiotic prophylaxis, and thorough information regarding antimicrobial resistance patterns is required.
Identifiants
pubmed: 31063845
pii: S2213-7165(19)30106-7
doi: 10.1016/j.jgar.2019.04.017
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Colistin
Z67X93HJG1
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
64-72Informations de copyright
Copyright © 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.